Latest News for: tgf-β
Edit
Oncotelic Therapeutics Details PDAOAI Platform and Opens Access to Its Total TGF-β Knowledge Corpus
Nasdaq Globe Newswire 22 Dec 2025
The Company is also providing researchers access to a TGF>-β literature corpus comprising all known publications for TGF-β- more ...
Edit
Henkel’s answer to ultra-demanding electronics applications: the Bergquist TGF 10000 thermal gap filler (Henkel AG & Co KGaA)
Public Technologies 10 Dec 2025
the Bergquist TGF> 10000 thermal gap filler. Henkel continues to drive innovation in thermal interface materials with the introduction of Bergquist TGF 10000, an advanced liquid gap filler that delivers 10 W/mK thermal conductivity.
Edit
Tiumbio to Present First Clinical Data for Dual TGF-β/VEGF Inhibitor Tosposertib (TU2218) at SITC 2025, "Robust Response Rate"
PR Newswire 10 Nov 2025
Tosposertib (TU2218) is a highly potent, oral dual inhibitor designed to block the signaling pathways of transforming growth factor-beta (TGF>-β) and vascular endothelial growth factor (VEGF), two critical mediators of tumor growth and metastasis.
Edit
SITC 2025 Poster Presentation: Dual targeting of TGF-b and EGFR with ficerafusp alfa shows superior antitumor activity over cetuximab in KRAS/BRAF wild-type MSS colorectal cancer cell lines (Bicara Therapeutics Inc)
Public Technologies 08 Nov 2025
Edit
The Taiwan Futures Exchange (TAIFEX) has announced the margin changed of TX, MTX, MXFFX, TMF, TE, ZEF, G2F, TJF, XAF, XEF, GDF, TGF, NYF, SRF, SR1, TXO, TEO and NYO. The margins will be effective after the close of the regular trading session on 2025/10/23. (TAIFEX - Taiwan Futures Exchange Corporation)
Public Technologies 22 Oct 2025
). The Taiwan Futures Exchange (TAIFEX) has announced the margin changed of TX, MTX, MXFFX, TMF, TE, ZEF, G2F, TJF, XAF, XEF, GDF,. TGF>, NYF, SRF, SR1, TXO, TEO and NYO ... Contracts. Currency. New Margin. Previous Margin. Initial Margin ... Clearing Margin ... 0 ... TGF.
Edit
The Galveston Daily News
19 Oct 2025
Incyte Announces Phase 1 Results for its TGFβR2×PD-1 Bispecific Antibody in Advanced Colorectal Cancer and ...
Edit
Caledonian Record
13 Oct 2025
Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the ...
Edit
A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T ...
PNAS 23 Sep 2025
SignificanceAdoptive T cell therapy has shown limited success in ...
Edit
TGF-β Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market ...
Nasdaq Globe Newswire 23 Sep 2025
Edit
Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer
PR Newswire 22 Sep 2025
AK130 is the world's first and only TIGIT/TGF>-β bifunctional antibody fusion protein in registrational clinical development ... It combines an anti-TIGIT monoclonal antibody with the extracellular domain of the human TGF-β receptor II.
- 1